offre-emploi


VP, Global Vaccine Strategy Lead, Shingles > 1849 GlaxoSmithKline Biologicals S.A. > Joboolo BE :


Société : 1849 GlaxoSmithKline Biologicals S.A.
Lieu : Wavre Wallonia
Site source : Talent BE



The role will be accountable for the Medical strategic direction of an Asset or Portfolio of assets and the matrix leadership of the Global Asset/Vaccine Medical Leadership Team, integrating innovative strategies that advance patient care.

The role will partner with key markets to ensure that their insights are used to inform all evidence, asset/vaccine development and strategic deliverables as well as partnering across Commercial and R&D to deliver value for patients.

In addition to leading the Global Asset Medical Leadership team, the incumbent will be a member of several additional matrix teams including the Vaccine Development Team and the Vaccine Commercial Team where he or she will provide Medical insight and expertise to inform and influence evidence generation and scientific communication plans across the lifecycle to optimize patient impact within markets.A key focus of the role is to develop and stretch self and team to be best in industry at delivering impact for patients and improving patient care paradigms.

The leader must exemplify GSK values and leadership behaviors.ResponsibilitiesMedical and Scientific Business LeadershipMaximise the positive impact for patients and GSK from early development to maturity (defined as no further significant clinical evidence generation).Accountable for developing and delivering the Global medical product strategy which shape the practice of medicine and associated Global deliverables enabling prioritized LOCs to execute the strategy and deliver positive patient impact locallyActing as a partner with the Vaccine Development Lead and Vaccines Commercialisation Lead, ensure integrated and thoughtful insights from across a diverse stakeholder set contribute to shaping the medicines/vaccine’s vision, development strategy and clinical development in the early phases of development, and for refining medical strategy as clinical evidence is generated.Ensure that medical insights from key countries are used to inform all evidence, product development, and franchise strategy deliverablesEnsure that the evidence generation plan aligns to the IEP and maximizes the product competitiveness and addresses prioritized evidence gaps from launch through lifecycle management for key LOCsOversee asset budget to ensure that resources are deployed against the highest the highest impact tacticsEnsure that Global deliverables are produced on time based on market needsUse a Global mindset, incorporating local perspectives, to strategy development and decision making.

Work across different major markets to understand their needs and balance options to achieve the set-out goals.Performance culture Maintains the patient at the center of everything we do.Full immersion in the science, disease area and business to be a true and equal partner to R&D, Commercial and Key LOCs.Outstanding matrix leadership through the creation of a collaborative and cross-functional environment by fostering shared accountability and responsibility for delivery of specific goals and projects, and encouraging employees to work with diverse skill sets and learn from each otherSeek out, actively listen to and understand the needs of key markets and ensure they are appropriately reflected in the global strategy, inclusive of evidence generation and all other deliverables.Assess and understands the external environment, inclusive of the competitor landscape, to bring insights together to develop a clear, simple, compelling Medical strategy to improve outcomes for patients Adopt a visionary and intuitive mindset, to anticipate current and future market value-drivers and evidence gaps and seek innovative solutions to them to support the long-term ambition for the asset/vaccine and its ultimate benefit for patientsQuickly adapt to unexpected external changes, understanding impact to strategy and ability to articulate implications for both R&D and commercialIntegrate and synthesize deep understanding of the end-to-end asset development processes, inclusive of commercialization and interconnectivities to deliver practice change and impact for patientsPeople Be a role model to all GSK employees, setting the right tone from the top while embedding a culture of performance underpinned by GSK Purpose, strategy and culture.Visibly leads with authenticity and confidence to gain followship for a workable plan, even in ambiguity.Creates cohesion and fellowship amongst the Medical Asset/Portfolio Leadership Team, especially with key/priority LOCs, maximizing its effectiveness as a decision-making unit, external impact and fostering collective accountability for success.Communicates consistently and with impact, with the goal that everyone who works on an asset understands and can implement the strategy.Adapt approaches for seeking input and feedback to accommodate cultural differences in LOCs.Outstanding leader of people, directly and indirectly, creating clarity in expectations and holding oneself and team accountableCreates an environment where our people can develop and thrive while holding a high-performance bar across organization which he/she leadsIdentify, attract, develop and retain talent and organizational capability for the futureLeads through uncertainty and ambiguity driving a culture of continuous improvement while building an agile learning organizationManages corporate reputation & builds trust Builds strong relationships across the enterprise to maximize synergies and impactFully understands the GSK Code and relevant policies governing our work enabling team members and self to always do the right thingUnderstands and proactively identifies risk developing mitigation plans aligned to our Internal Control FrameworkDevelop, gain approval for, and manage the annual budget required to deliver the objectives for in line with defined processes and policiesQualificationsBasic:

Qualifications
- MD/MBBS/PharmD or PhD in Vaccinology or Infectious DiseasesScientific and Medical Knowledge
- Experience of working within Vaccines Medical AffairsLeadership
- Experience in Medical Affairs as a therapy area lead in a major market and an asset lead role at the global level.Medical Affairs
- Asset launch experience, with design and execution of in country and above country strategies.Clinical Development
- Experience in the design, development, execution, statistical analysis, clinical interpretation and reporting of high-quality clinical studies.Agility
- Experience of assimilating information rapidly to identify critical questions that will drive decision-making and planning.Strategic Thinking
- Experience of carefully considering the issues and competing priorities within a situation, program or portfolio and then developing a strategy that includes the strategic application of available principles, tools, and systems.Business Acumen
- Experience of making decisions related to human, financial, material and information resources and using this knowledge to plan medical affairs strategy and resourcing.Reimbursement/Market Access Knowledge
- Experience of working closely with Value Evidence and Outcomes groups to support the payer value proposition.People Development and Performance Management – Experience of building and maintaining a high performing team with appropriate performance managementPreferred:

Medical Doctor with experience of successful asset launches and lifecycle management within Vaccines Medical AffairsWell-developed communication and influencing skills with the ability to distil complexity down to what matters most to our stakeholders .

Strong financial/budget and project management skills as well as business acumen.Maintenance of high professional standards and adherence to internal and external codes of practiceIf you have a disability and require assistance during the course of the selection process, you will have the opportunity to let us know what specific assistance you require in order to make suitable arrangements.Why Us?GSK is a global biopharma company with a special purpose – to unite science, technology and talent to get ahead of disease together – so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns – as an organization where people can thrive.

Getting ahead means preventing disease as well as treating it, and we aim to positively impact the health of 2.5 billion people by the end of 2030.Our success absolutely depends on our people.

While getting ahead of disease together is about our ambition for patients and shareholders, it’s also about making GSK a place where people can thrive.

We want GSK to be a workplace where everyone can feel a sense of belonging and thrive as set out in our Equal and Inclusive Treatment of Employees policy.

We’re committed to being more proactive at all levels so that our workforce reflects the communities we work and hire in, and our GSK leadership reflects our GSK workforce.Important notice to Employment businesses/ AgenciesGSK does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site.

All employment businesses/agencies are required to contact GSK's commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to GSK.

The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business/ agency and GSK.

In the absence of such written authorization being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of GSK.
1849 GlaxoSmithKline Biologicals S.A.
Wavre Wallonia




Nouvelle recherche d'emploi VP, Global Vaccine Strategy Lead, Shingles

Plus d'offres 1849 GlaxoSmithKline Biologicals S.A.

VP, Global Vaccine Strategy Lead, Shingles - Lieu : Wavre Wallonia - Société : 1849 GlaxoSmithKline Biologicals S.A.

VP, Global Vaccine Strategy Lead, Shingles - Lieu : Wavre Wallonia - Société : 1849 GlaxoSmithKline Biologicals S.A.

VP, Global Vaccine Strategy Lead, Shingles - Lieu : Wavre Wallonia - Société : 1849 GlaxoSmithKline Biologicals S.A.







Offres d'emploi fournis par offre-emploi ==> Belgium